Assignee
SHANGHAI LONGXIN BIOMEDICAL TECH CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
3 records- 0148US2023051694A1Polypeptide fragment b (mp-b) and use thereofSHANGHAI LONGXIN BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0245US2022402973A1Polypeptide fragment c (mp-c) and use thereofSHANGHAI LONGXIN BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0345US2022402982A1Polypeptide fragment d (mp-d) and use thereofSHANGHAI LONGXIN BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI LONGXIN BIOMEDICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →